Xiaohai Gong

724 total citations
20 papers, 591 citations indexed

About

Xiaohai Gong is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Xiaohai Gong has authored 20 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Oncology. Recurrent topics in Xiaohai Gong's work include Virus-based gene therapy research (2 papers), DNA Repair Mechanisms (2 papers) and Reproductive Biology and Fertility (2 papers). Xiaohai Gong is often cited by papers focused on Virus-based gene therapy research (2 papers), DNA Repair Mechanisms (2 papers) and Reproductive Biology and Fertility (2 papers). Xiaohai Gong collaborates with scholars based in China, United States and Uganda. Xiaohai Gong's co-authors include David J. Miller, Barry D. Shur, Daniel H. Dubois, Karen L. Marquis, Hua Zhou, Menelas N. Pangalos, Robert Martone, J. Steven Jacobsen, Suzan Aschmies and Thomas A. Comery and has published in prestigious journals such as Science, Journal of Neuroscience and Development.

In The Last Decade

Xiaohai Gong

20 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohai Gong China 10 248 170 146 132 103 20 591
Christian Lessard United States 12 270 1.1× 182 1.1× 133 0.9× 142 1.1× 62 0.6× 19 694
Gustavo A. Barisone United States 13 355 1.4× 246 1.4× 38 0.3× 41 0.3× 129 1.3× 27 692
Arpita Ray United States 13 229 0.9× 127 0.7× 161 1.1× 139 1.1× 95 0.9× 19 749
Debby Ickowicz Israel 15 305 1.2× 95 0.6× 301 2.1× 256 1.9× 123 1.2× 19 846
Ching‐Hsiang Wu Taiwan 14 222 0.9× 63 0.4× 60 0.4× 55 0.4× 108 1.0× 22 670
Taiji Asami Japan 17 511 2.1× 115 0.7× 218 1.5× 19 0.1× 346 3.4× 51 982
Young‐Hwan Kim South Korea 14 218 0.9× 56 0.3× 80 0.5× 64 0.5× 73 0.7× 39 503
Lavoisier Ramos‐Espiritu United States 10 334 1.3× 138 0.8× 38 0.3× 55 0.4× 105 1.0× 12 597
Hong Tian China 15 394 1.6× 80 0.5× 52 0.4× 33 0.3× 95 0.9× 37 854
Robert Dedecker Belgium 12 210 0.8× 287 1.7× 19 0.1× 25 0.2× 111 1.1× 14 696

Countries citing papers authored by Xiaohai Gong

Since Specialization
Citations

This map shows the geographic impact of Xiaohai Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohai Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohai Gong more than expected).

Fields of papers citing papers by Xiaohai Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohai Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohai Gong. The network helps show where Xiaohai Gong may publish in the future.

Co-authorship network of co-authors of Xiaohai Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohai Gong. A scholar is included among the top collaborators of Xiaohai Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohai Gong. Xiaohai Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xu, Yun Chen, Jingyu Zhu, et al.. (2021). A comprehensive screening method for investigating the potential binding targets of doxorubicin based on protein microarray. European Journal of Pharmacology. 896. 173896–173896. 7 indexed citations
2.
Wang, Xu, et al.. (2019). Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells. Frontiers in Pharmacology. 10. 1434–1434. 18 indexed citations
3.
Zhou, Songtao, Yun Chen, Xiaohai Gong, Jian Jin, & Huazhong Li. (2019). Site-specific integration of light chain and heavy chain genes of antibody into CHO-K1 stable hot spot and detection of antibody and fusion protein expression level. Preparative Biochemistry & Biotechnology. 49(4). 384–390. 10 indexed citations
4.
Zhou, Songtao, Xuefeng Ding, Yun Chen, et al.. (2019). Discovery of a stable expression hot spot in the genome of Chinese hamster ovary cells using lentivirus-based random integration. Biotechnology & Biotechnological Equipment. 33(1). 605–612. 10 indexed citations
5.
Chen, Shuxian, Xu Wang, Donghui Ma, et al.. (2017). Identification of Human UMP/CMP Kinase 1 as Doxorubicin Binding Target Using Protein Microarray. SLAS DISCOVERY. 22(8). 1007–1015. 7 indexed citations
6.
Hou, Ying, Min Chu, Yanfei Cai, et al.. (2015). Antitumor and anti-angiogenic activity of the recombinant human disintegrin domain of A disintegrin and metalloproteinase 15. Molecular Medicine Reports. 12(2). 2360–2366. 4 indexed citations
7.
8.
Chen, Zhen, Xiaohai Gong, Yanfei Cai, et al.. (2015). β-Catenin expression is regulated by an IRES-dependent mechanism and stimulated by paclitaxel in human ovarian cancer cells. Biochemical and Biophysical Research Communications. 461(1). 21–27. 12 indexed citations
9.
Qian, Kai, Xiaohai Gong, Bo Guan, et al.. (2015). Efficient expression of glucagon-like peptide-1 analogue with human serum albumin fusion protein in Pichia pastoris using the glyceraldehyde-3-phosphate dehydrogenase promoter. Biotechnology and Bioprocess Engineering. 20(4). 694–700. 5 indexed citations
10.
Ma, Xin, et al.. (2014). Recombinant human interleukin 24 reverses Adriamycin resistance in a human breast cancer cell line. Pharmacological Reports. 66(5). 915–919. 6 indexed citations
11.
Yang, Xueli, et al.. (2014). JF-305, a pancreatic cancer cell line is highly sensitive to the PARP inhibitor olaparib. Oncology Letters. 9(2). 757–761. 13 indexed citations
12.
Yang, Xueli, et al.. (2014). CHK21100delC, I157T, IVS2 +IG > A, BRCA1 and BRCA2 Mutation Analysis in JF305: A Pancreatic Cancer Cell Line. Journal of Biosciences and Medicines. 2(1). 58–67. 1 indexed citations
13.
Gong, Xiaohai, et al.. (2013). Cost-effective production of recombinant human interleukin 24 by lactose induction and a two-step denaturing and one-step refolding method. Journal of Industrial Microbiology & Biotechnology. 41(1). 135–142. 6 indexed citations
14.
15.
Zhang, Jie, Diana Chen, Xiaohai Gong, et al.. (2006). Cyclic-AMP Response Element-Based Signaling Assays for Characterization of Trk Family Tyrosine Kinases Modulators. Neurosignals. 15(1). 26–39. 9 indexed citations
16.
Cho, Seongeun, Xiaohai Gong, Huai‐Ping Ling, et al.. (2006). Croucher Advanced Study Institute (ASI): Signaling in Cell Growth and Differentiation. Abstract collection date: 16–20 January 2006. Neurosignals. 15(1). 40–52. 6 indexed citations
17.
Liu, Feng, Xiaohai Gong, Guoming Zhang, et al.. (2005). The inhibition of glycogen synthase kinase 3β by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Aβ peptides. Journal of Neurochemistry. 95(5). 1363–1372. 36 indexed citations
18.
Comery, Thomas A., Robert Martone, Suzan Aschmies, et al.. (2005). Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease. Journal of Neuroscience. 25(39). 8898–8902. 176 indexed citations
19.
Gong, Xiaohai, Daniel H. Dubois, David J. Miller, & Barry D. Shur. (1995). Activation of a G Protein Complex by Aggregation of β-1,4-Galactosyltransferase on the Surface of Sperm. Science. 269(5231). 1718–1721. 125 indexed citations
20.
Miller, David J., Xiaohai Gong, & Barry D. Shur. (1993). Sperm require β-N-acetylglucosaminidase to penetrate through the egg zona pellucida. Development. 118(4). 1279–1289. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Lessard Breakdown of academic impact, for papers by Gustavo A. Barisone Breakdown of academic impact, for papers by Arpita Ray Breakdown of academic impact, for papers by Debby Ickowicz Breakdown of academic impact, for papers by Ching‐Hsiang Wu Breakdown of academic impact, for papers by Taiji Asami Breakdown of academic impact, for papers by Young‐Hwan Kim Breakdown of academic impact, for papers by Lavoisier Ramos‐Espiritu Breakdown of academic impact, for papers by Hong Tian Breakdown of academic impact, for papers by Robert Dedecker
Rankless by CCL
2026